Found 65 results
Filters: Author is Glodzik, Lidia  [Clear All Filters]
2016
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2016.  Clearance systems in the brain--implications for Alzheimer diseaser.. Nat Rev Neurol. 12(4):248.
Glodzik L, Rusinek H, Kamer A, Pirraglia E, Tsui W, Mosconi L, Li Y, McHugh P, Murray J, Williams S et al..  2016.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.. Alzheimers Dement (Amst). 2:95-104.
Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al..  2016.  Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.
Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V et al..  2016.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.. Sleep. 39(6):1253-60.
Kamer AR, Fortea JO, Videla S, Mayoral A, Janal M, Carmona-Iragui M, Benejam B, Craig RG, Saxena D, Corby P et al..  2016.  Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome.. Alzheimers Dement (Amst). 2:49-57.
Varga AW, Wohlleber ME, Giménez S, Romero S, Alonso JF, Ducca EL, Kam K, Lewis C, Tanzi EB, Tweardy S et al..  2016.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.. Sleep. 39(11):2041-2048.